Literature DB >> 35780727

The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis.

Devi Sai Sri Kavya Boorgu1, Shruthi Venkatesh1, Chirag M Lakhani2, Elizabeth Walker1, Ines M Aguerre3, Claire Riley3, Chirag J Patel2, Philip L De Jager3, Zongqi Xia4.   

Abstract

BACKGROUND: To examine whether lower neighborhood-level and individual-level indicators of socioeconomic status (SES) are associated with subsequently worse neurological disability in people with MS (pwMS).
METHODS: In a multi-center study using prospectively collected data from discovery cohorts (University of Pittsburgh, N=1316) and replication cohorts (Columbia University, N=488), we calculated a neighborhood SES indicator, area deprivation index (ADI), based on participants' residence at enrollment, and we derived an individual SES indicator based on participants' household income. Patient-reported neurological outcomes included the Multiple Sclerosis Rating Scale-Revised (MSRS-R), Patient-Determined Disease Steps (PDDS), and Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function scores from 2018 to 2020. We performed covariate-adjusted regression analyses in each cohort and then random-effects meta-analyses.
RESULTS: Higher ADI (lower SES) in 2015 was associated with subsequently worse neurological outcomes during 2018-2020 (discovery: MSRS-R, β=0.62, 95%CI [0.36,0.89], p<0.001; PDDS, β=0.11, 95%CI [0.02,0.20], p=0.02 | replication: MSRS-R, β=0.46, 95%CI [0.21,0.72], p<0.001; PDDS, β=0.12, 95%CI [0.03,0.21], p=0.009, PROMIS, β=-0.60, 95%CI [-1.12,-0.08], p=0.025). Lower neighborhood percent with college education (MSRS-R, β=-7.31, 95%CI [-8.99,-5.64], p<0.001; PDDS, β=-1.62, 95%CI [-2.20,-1.05], p<0.001; PROMIS, β=9.31, 95%CI [5.73,12.89], p<0.001), neighborhood median household income (MSRS-R, β=-3.80e-05, 95%CI [-5.05e-05,-2.56e-05], p<0.001; PDDS, β=-8.58e-06, 95%CI [-1.28e-05,-4.32e-06], p<0.001; PROMIS, β=2.55e-05, 95%CI [5.96e-07,5.05e-05], p=0.045), and neighborhood median home value (MSRS-R, β=-6.50e-06, 95%CI [-8.16e-06,-4.84e-06], p<0.001; PDDS, β=-1.54e-06, 95%CI [-2.11e-06,-9.65e-07], p<0.001; PROMIS, β=4.98e-06, 95%CI [1.81e-06,8.14e-06], p=0.002) drove the association between higher ADI and subsequently worse neurological disability (in joint analyses). Neighborhood percent of population with Medicaid, but not private insurance, significantly mediated the observed covariate-adjusted associations. Higher individual-level household income bracket was associated with better neurological outcomes in joint analyses (MSRS-R: R=-0.39, p<0.001; PDDS: R=-0.35, p<0.001; PROMIS: R=0.37, p<0.001), independent of ADI.
CONCLUSIONS: Lower neighborhood SES is associated with subsequently worse neurological outcomes in pwMS. Future testing of targeted intervention through public policies that improve SES are warranted.
Copyright © 2022. Published by Elsevier B.V.

Entities:  

Keywords:  Area deprivation index; Disability; Insurance; Multiple sclerosis; Neurological outcome; Socioeconomic status

Mesh:

Year:  2022        PMID: 35780727      PMCID: PMC9444968          DOI: 10.1016/j.msard.2022.103994

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.808


  57 in total

Review 1.  The impact of health insurance on health.

Authors:  Helen Levy; David Meltzer
Journal:  Annu Rev Public Health       Date:  2008       Impact factor: 21.981

2.  Gradient of disability across the socioeconomic spectrum in the United States.

Authors:  Meredith Minkler; Esme Fuller-Thomson; Jack M Guralnik
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

3.  The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.

Authors:  David Cella; William Riley; Arthur Stone; Nan Rothrock; Bryce Reeve; Susan Yount; Dagmar Amtmann; Rita Bode; Daniel Buysse; Seung Choi; Karon Cook; Robert Devellis; Darren DeWalt; James F Fries; Richard Gershon; Elizabeth A Hahn; Jin-Shei Lai; Paul Pilkonis; Dennis Revicki; Matthias Rose; Kevin Weinfurt; Ron Hays
Journal:  J Clin Epidemiol       Date:  2010-08-04       Impact factor: 6.437

Review 4.  Disease-modifying treatments for early and advanced multiple sclerosis: a new treatment paradigm.

Authors:  Gavin Giovannoni
Journal:  Curr Opin Neurol       Date:  2018-06       Impact factor: 5.710

5.  Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS.

Authors:  J F Kurtzke; W F Page
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

6.  Socioeconomic factors in childhood and the risk of multiple sclerosis.

Authors:  Nete Munk Nielsen; Kristian T Jørgensen; Peter Bager; Egon Stenager; Bo V Pedersen; Henrik Hjalgrim; Nils Koch-Henriksen; Morten Frisch
Journal:  Am J Epidemiol       Date:  2013-05-09       Impact factor: 4.897

7.  Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk.

Authors:  Zongqi Xia; Charles C White; Emily K Owen; Alina Von Korff; Sarah R Clarkson; Cristin A McCabe; Maria Cimpean; Phoebe A Winn; Ashley Hoesing; Sonya U Steele; Irene C M Cortese; Tanuja Chitnis; Howard L Weiner; Daniel S Reich; Lori B Chibnik; Philip L De Jager
Journal:  Ann Neurol       Date:  2015-12-09       Impact factor: 10.422

8.  Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course.

Authors:  Riley Bove; Elizabeth Secor; Brian C Healy; Alexander Musallam; Timothy Vaughan; Bonnie I Glanz; Emily Greeke; Howard L Weiner; Tanuja Chitnis; Paul Wicks; Philip L De Jager
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

9.  Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.

Authors:  Kjetil Bjørnevik; Trond Riise; Marianna Cortese; Trygve Holmøy; Margitta T Kampman; Sandra Magalhaes; Kjell-Morten Myhr; Christina Wolfson; Maura Pugliatti
Journal:  Mult Scler       Date:  2015-05-26       Impact factor: 6.312

Review 10.  Advances in the Treatment of Multiple Sclerosis.

Authors:  Carolyn Goldschmidt; Marisa P McGinley
Journal:  Neurol Clin       Date:  2020-11-07       Impact factor: 3.806

View more
  1 in total

1.  Predicting Multiple Sclerosis Outcomes During the COVID-19 Stay-at-home Period: Observational Study Using Passively Sensed Behaviors and Digital Phenotyping.

Authors:  Anind Dey; Mayank Goel; Zongqi Xia; Prerna Chikersal; Shruthi Venkatesh; Karman Masown; Elizabeth Walker; Danyal Quraishi
Journal:  JMIR Ment Health       Date:  2022-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.